Psoriasis
The Psoriasis pipeline: 113 tracked drugs, 48 approved for this indication.
48 approved / phase 427 Phase 33 Phase 2/321 Phase 22 Phase 1/29 Phase 13 preclinical / unstaged
Compare the share prices of listed companies in Psoriasis →
Total attributable cost
$28.4B
$3,592/patient
Drug spend
Not yet sourced
All severities, physician-diagnosed history (2023 NHIS) · US
The Psoriasis pipeline
Key trial results for every approved and late-stage drug: Psoriasis results by drug.